Metformin as targeted treatment in fragile X syndrome.

about

The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?Fragile X syndrome and fragile X-associated disorders.Of Men and Mice: Modeling the Fragile X Syndrome.

P2860

Q47110293-1466288F-4B86-4EDD-93CE-F08C7FB54A5E Q47140616-DDA14648-E181-44FA-B06B-51340D6EEBEA Q53422584-E54D88A3-5F25-4709-AB8F-7993A28AD132

P2860

Metformin as targeted treatment in fragile X syndrome.

Item

http://www.wikidata.org/entity/Q45075643

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metformin as targeted treatment in fragile X syndrome.

@en

Metformin as targeted treatment in fragile X syndrome.

@nl

type

Item

label

Metformin as targeted treatment in fragile X syndrome.

@en

Metformin as targeted treatment in fragile X syndrome.

@nl

prefLabel

Metformin as targeted treatment in fragile X syndrome.

@en

Metformin as targeted treatment in fragile X syndrome.

@nl

P1476

Metformin as targeted treatment in fragile X syndrome

@en

P2093

F Tassone

http://www.w3.org/2001/XMLSchema#string

M Eldeeb

http://www.w3.org/2001/XMLSchema#string

N Tartaglia

http://www.w3.org/2001/XMLSchema#string

R Hagerman

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

Advances in the treatment of fragile X syndrome

Fragile x syndrome

The neurobiology of the Prader-Willi phenotype of fragile X syndrome

Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization.

Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

Metformin for obesity in children and adolescents: a systematic review.

Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model.

Fragile X syndrome: a review of associated medical problems.

AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity.

P304

216-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CGE.13039

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Salcedo-Arellano

A B C Dy

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28436599

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

6944702

http://www.w3.org/2001/XMLSchema#string

Metformin as targeted treatment in fragile X syndrome.

about

P2860

P2860

Metformin as targeted treatment in fragile X syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932